It is with great pleasure that we are announcing the 2nd edition of the MEG@51勛圖厙Comprehensive Training Program in 2015.3801 rue University, Montreal, QC, H3A 2B4, CA/bicCategory:MNI
Since becoming only the second Alzheimers-modifying drug to gain American FDA approval in 2023, sales of lecanemab, known by its brand name Leqembi, have risen steadily, reaching $87-million USD...